{"name": "EGEN",
 "permalink": "egen",
 "crunchbase_url": "http://www.crunchbase.com/company/egen",
 "homepage_url": "http://www.egeninc.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@egeninc.com",
 "phone_number": "1-256-512-0077",
 "description": "Biopharm. Company",
 "created_at": "Wed Jun 24 12:03:56 UTC 2009",
 "updated_at": "Wed Jun 24 17:36:10 UTC 2009",
 "overview": "\u003Cp\u003EEGEN, Inc., is an Alabama-based specialty biopharmaceutical company developing safe and efficient delivery systems to be used to create products for treatment of human diseases. Their synthetic biocompatible delivery vehicles can be used to deliver therapeutic genes, inhibitory RNA (siRNA \u0026amp; shRNA) and small molecules. The delivery systems function by protecting the therapeutic cargo from degradation, promoting uptake by the target cells and facilitating intracellular trafficking. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[107,
       68],
      "assets/images/resized/0005/0487/50487v1-max-150x150.jpg"],
     [[107,
       68],
      "assets/images/resized/0005/0487/50487v1-max-250x250.jpg"],
     [[107,
       68],
      "assets/images/resized/0005/0487/50487v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and Chief Scientific Officer ",
    "person":
     {"first_name": "Khursheed",
      "last_name": "Anwer",
      "permalink": "khursheed-anwer",
      "image": null}},
   {"is_past": false,
    "title": "Senior Vice President, Corporate Development",
    "person":
     {"first_name": "James",
      "last_name": "A. McCarthy",
      "permalink": "james-a-mccarthy",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$12M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104\u0026STORY=/www/story/08-04-2008/0004860884\u0026EDATE=",
    "source_description": "Expression Genetics Inc., Specializing in DNA/RNAi Delivery and Therapeutics, Completes $12M Series B Financing",
    "raised_amount": 12000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 8,
    "funded_day": 4,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "601 Genome Way ",
    "address2": "",
    "zip_code": "35806",
    "city": "Huntsville",
    "state_code": "AL",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        89],
       "assets/images/resized/0005/0488/50488v1-max-150x150.jpg"],
      [[250,
        148],
       "assets/images/resized/0005/0488/50488v1-max-250x250.jpg"],
      [[450,
        267],
       "assets/images/resized/0005/0488/50488v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}